Pathology Industry in Europe Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

About 1 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Europe

  • December 2014
    7 pages
  • Mental Health  

  • Europe  

    World  

View report >

Pathology Description in Europe

  • November 2014
    37 pages
  • Hiv  

  • Europe  

    Spain  

    Italy  

View report >

Pathology Description in Europe

  • November 2014
    77 pages
  • Respiratory Dis...  

    Occupational He...  

    Public Health  

  • United Kingdom  

    Europe  

View report >

Pathology Description in Europe - Forecast

  • November 2014
    7 pages
  • Mental Health  

  • Europe  

    World  

View report >

Pathology Description

  • October 2014
    7 pages
  • Breast Cancer  

  • Europe  

    United States  

View report >

Pathology Description

  • October 2014
    39 pages
  • Influenza  

  • Europe  

    Sweden  

    Italy  

View report >

Pathology Description in Europe

  • October 2014
    23 pages
  • Pathology  

    Pharmaceutical  

  • Europe  

    United States  

    Japan  

View report >

Pathology Description in Europe

  • October 2014
    12 pages
  • Pathology  

  • Europe  

    United States  

    Switzerland  

View report >

Pathology Description in Europe

  • October 2014
    18 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Pathology Description in Europe

  • September 2014
    21 pages
  • Pathology  

  • France  

    Europe  

    Denmark  

View report >

Search in Pathology Industry

About 400 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 300 - $ 6 995)

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in ...

Epicast Report: Rheumatoid Arthritis - Epidemiology For ...

December 2014 $ 3 995

Medical Affairs Reputations In Oncology (eu5): Oncologi ...

December 2014 $ 3 900

Herceptin (her2-positive Breast Cancer) - Forecast And ...

September 2014 $ 3 495

Perjeta (her2-positive Breast Cancer) - Forecast And Ma ...

September 2014 $ 3 495

Kadcyla (her2-positive Breast Cancer) - Forecast And Ma ...

September 2014 $ 3 495

Tykerb (her2-positive Breast Cancer) - Forecast And Mar ...

September 2014 $ 3 495

Neratinib (her2-positive Breast Cancer) - Forecast And ...

September 2014 $ 3 495

Eu: Hearing Aids (excl. Parts And Accessories) - Market ...

December 2014 $ 2 161

Connected Care In Europe

October 2014 $ 1 610


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.